Authors



Daniel J. Klein

Latest:

Seeking Innovative Solutions to Patient Cost Sharing

An interview with The American Journal of Managed Care about the PAN Challenge grant.



Peter Boland, PhD

Latest:

Living While at High Risk of Developing Alzheimer Disease

In 2017, an estimated 5.5 million Americans were diagnosed with Alzheimer disease (AD) and 200,000 under 65 years of age are described as having early-onset AD. Even more striking is the finding that 47 million Americans are presymptomatic with stage I AD. These dire statistics beg the question about the merits of getting tested for AD since lifestyle changes can help people at risk, but they are less likely to improve the conditions of those already experiencing cognitive impairment or dementia.


The Alliance for Physical Therapy Quality and Innovation

Latest:

Payers: Embrace the Value of Physical Therapy to Reduce Costs

As our country continues its push to lower the cost of healthcare, especially among the burgeoning population of seniors with age-related disabilities, transitioning to a value-based insurance design payment model that rewards value, rather than quantity, will become progressively more important. In the realms of musculoskeletal pain and movement dysfunction, this transition must be accompanied with sincere efforts to identify treatments that can effectively manage pain and reduce the total cost of care.



Paul Grundy

Latest:

Contributor: How a Health Cloud Can Help Create Seamless Virtual Health Care Experience in a Post–COVID-19 World

Patients worldwide are reluctant to visit clinics and hospitals amid fears of COVID-19. Implementing virtual care capabilities can not only relieve the patients of this fear by minimizing in-person exposure and preventing the virus from spreading, but also improve patient-centered care delivery.




Andria Jacobs, RN, MS, CEN, CPHQ

Latest:

Contributor: Agility Required to Keep Pace With Code Changes During Pandemic

Andria Jacobs, RN, MS, CEN, CPHQ, chief operating officer for PCG Software, discusses 3 billing and claims issues facing the health care industry in the wake of the COVID-19 pandemic. 



Mandi Bishop, MA

Latest:

Andy Slavitt: Patient Advocate, Public Servant, Model of Government Leadership Transparency

As we approach the January 20 inauguration of Donald J. Trump as the 45th president of the United States, we come to the end of an all-too-brief era of unparalleled government transparency and leadership accessibility: Acting Administrator of CMS Andy Slavitt will be stepping down from his post.


John Peabody, MD, PhD, FACP

Latest:

Healthcare Re-Reform: Value-Based Care Remains a Constant Theme

While many questions on the outlook of healthcare “re-reform” remain afloat, many important insights into President Donald Trump’s potential path forward are now identified.


Ara Ohanian

Latest:

The ROI of Addressing Social Determinants of Health

Convincing your chief financial officer to invest in technology that addresses patients’ social determinants of health.


Michele Brown

Latest:

Hear me roar!

Read how being denied new technology by my insurance company impacts me.



OneOncology

Latest:

2019 Is Off to a Great Start—Take a Leading Role

Moving from a comfortable place to one with new paths, new experiences, and new goals is both challenging and invigorating at the same time. Good fortune is when you choose to change because the future belongs to those who adapt.


Sarah Hallberg, DO, MS

Latest:

Type 2 Diabetes: Changing the Paradigm From Management to Reversal

Results from the first 70 days of the Virta Clinic trial suggest the historic dietary approach to management of type 2 diabetes has been all wrong.


Donna R. Cryer, JD

Latest:

Is the QALY Fit for Purpose?

The quality-adjusted life-year (QALY) is a popular tool for value assessment but is flawed. This paper highlights potential solutions.


Win Whitcomb, MD, MHM

Latest:

The New CMS Bundle Model: Understanding Key Decision Points for Program Participation

There's only a month until the application portal closes for the Bundled Payment for Care Improvement Advanced initiative, the first value-based model launched under the Trump administration.


Shannon Wiggins

Latest:

How Will FY2020 IPPS Proposed Rule Affect Hospital CDI Programs?

The fiscal year 2020 (FY2020) Inpatient Prospective Payment Systems (IPPS) proposed rule notably includes approximately 1500 complications or comorbidities (CC)/major complications or comorbidities (MCC) designation changes and 324 changes to International Classification of Diseases, Tenth Revision, Clinical Modification codes, along with several other updates. The designation changes are an effort to respond to the notion that the CC/MCC assignment are no longer appropriate as conditions and factors have shifted.



Jeffrey Dlott, MD

Latest:

The Whole Patient and Nothing but the Patient

Chronic care management is available under Medicare but has been underused thus far.


Randy Tomlin

Latest:

Take an App and (Don't) Call Me in the Morning

How can perioperative mobile apps can increase patient compliance while saving money?


Samantha Eisenstein Watson, MBA

Latest:

Having Cancer Saved My Life

A Samfund grant recipient narrates her experience of being diagnosed young with cancer and how the support from The Samfund "made everyday school and life manageable."



Tashfeen Ekram, MD

Latest:

Population Health Starts With Access to Care

Access and quality are inseparable, so providers prioritizing population health goals can find success by starting from a solid foundation of patient access. So how can providers streamline access to care and directly influence population health? The answer lies with sophisticated patient engagement technology.



John Rehm

Latest:

Will Your State Have a Shortage of Nurses in the Next Decade?

Overall, the United States is predicted to see a shortage of 193,000 nursing professionals by 2020, according to a 2015 report.


Joey Mattingly, PharmD, MBA

Latest:

Pharmacoeconomics Refresher: The CVS $100k/QALY Announcement (Part 3)

In this series, we have used the recent announcement by CVS Health regarding a strategy to lower drug prices as an example to review basic pharmacoeconomic principles. For Part 3, we are going to discuss various stakeholders and how each might view the results of decisions based off of pharmacoeconomic analyses.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo